Rising Biopharma R&D Demand Fuels High Throughput Process Development Market According to a newly published market research report by 24LifeSciences, global High Throughput Process Development market is valued at USD 406 million in 2026 and is projected to reach USD 909 million by 2034, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period. High-throughput process development (HTPD) represents a paradigm shift in bioprocessing, integrating miniaturization, automation, and parallelization to create a systematic and highly efficient approach for chromatography and purification process development. This methodology is crucial for accelerating the optimization of biopharmaceutical manufacturing processes, significantly reducing both development time and resource consumption while ensuring robust and scalable production. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9280/high-throughput-process-development-market

Rising Biopharma R&D Demand Fuels High Throughput Process Development Market According to a newly published market research report by 24LifeSciences, global High Throughput Process Development market is valued at USD 406 million in 2026 and is projected to reach USD 909 million by 2034, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period. High-throughput process development (HTPD) represents a paradigm shift in bioprocessing, integrating miniaturization, automation, and parallelization to create a systematic and highly efficient approach for chromatography and purification process development. This methodology is crucial for accelerating the optimization of biopharmaceutical manufacturing processes, significantly reducing both development time and resource consumption while ensuring robust and scalable production. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9280/high-throughput-process-development-market

Monoclonal Antibody Custom Service Market Size to Reach USD 1.63 Billion by 2032 Global monoclonal antibody custom service market is entering a phase of sustained expansion as biologics, precision medicine, and translational research reshape modern drug development. Valued at USD 1,055 million in 2024, the market is projected to grow from USD 1,123 million in 2025 to USD 1,634 million by 2032, registering a compound annual growth rate (CAGR) of 6.6% over the forecast period. Increasing reliance on bespoke antibody solutions across biopharmaceutical R&D, diagnostics, and oncology-focused research is reinforcing the strategic importance of custom antibody services worldwide. Access the market report https://www.24lifesciences.com/monoclonal-antibody-custom-service-market-9539